172 related articles for article (PubMed ID: 17382246)
41. Higher levels of free plasma mitochondrial DNA are associated with the onset of chronic GvHD.
Rozmus J; Ivison S; Kariminia A; Leung VM; Sung S; Subrt P; Lee SJ; Boilard E; Walker I; Foley R; Lipton J; Gallagher G; Couban S; Schultz KR
Bone Marrow Transplant; 2018 Oct; 53(10):1263-1269. PubMed ID: 29563589
[TBL] [Abstract][Full Text] [Related]
42. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
[TBL] [Abstract][Full Text] [Related]
43. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.
Fujii H; Cuvelier G; She K; Aslanian S; Shimizu H; Kariminia A; Krailo M; Chen Z; McMaster R; Bergman A; Goldman F; Grupp SA; Wall DA; Gilman AL; Schultz KR
Blood; 2008 Mar; 111(6):3276-85. PubMed ID: 17925486
[TBL] [Abstract][Full Text] [Related]
44. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
[TBL] [Abstract][Full Text] [Related]
45. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
46. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
[TBL] [Abstract][Full Text] [Related]
47. Quantitative analysis of Langerhans' cells in oral chronic graft-vs.-host disease.
Orti-Raduan ES; Nunes AJ; Oliveira DT; Lara VS; Taveira LA
J Oral Pathol Med; 2009 Jan; 38(1):132-7. PubMed ID: 19054287
[TBL] [Abstract][Full Text] [Related]
48. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
[TBL] [Abstract][Full Text] [Related]
49. Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-alpha.
Schroeder JT; Chichester KL; Bieneman AP
J Allergy Clin Immunol; 2008 Feb; 121(2):486-91. PubMed ID: 18036648
[TBL] [Abstract][Full Text] [Related]
50. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
[TBL] [Abstract][Full Text] [Related]
51. Predominant infiltration of monocytes in chronic graft-versus-host disease.
Namba N; Shinagawa K; Fujii N; Maeda Y; Ishimaru F; Ikeda K; Matsui T; Tanimoto M; Katayama Y
Transplantation; 2007 Jan; 83(2):220-4. PubMed ID: 17264819
[TBL] [Abstract][Full Text] [Related]
52. B cells in chronic graft-versus-host disease.
McManigle W; Youssef A; Sarantopoulos S
Hum Immunol; 2019 Jun; 80(6):393-399. PubMed ID: 30849450
[TBL] [Abstract][Full Text] [Related]
53. Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.
Rubegni P; Cuccia A; Sbano P; Cevenini G; Carcagnì MR; D'Ascenzo G; De Aloe G; Guidi S; Guglielmelli P; Marotta G; Lauria F; Bosi A; Fimiani M
Br J Haematol; 2005 Jul; 130(2):271-5. PubMed ID: 16029456
[TBL] [Abstract][Full Text] [Related]
54. Influence of bone marrow graft B lymphocyte subsets on outcome after HLA-identical sibling transplants.
Michonneau D; Peffault de Latour R; Porcher R; Robin M; Benbunan M; Rocha V; Ribaud P; Ferry C; Devergie A; Vanneaux V; Gluckman E; Marolleau JP; Socié G; Larghero J
Br J Haematol; 2009 Apr; 145(1):107-14. PubMed ID: 19183190
[TBL] [Abstract][Full Text] [Related]
55. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.
Loiseau P; Busson M; Balere ML; Dormoy A; Bignon JD; Gagne K; Gebuhrer L; Dubois V; Jollet I; Bois M; Perrier P; Masson D; Moine A; Absi L; Reviron D; Lepage V; Tamouza R; Toubert A; Marry E; Chir Z; Jouet JP; Blaise D; Charron D; Raffoux C
Biol Blood Marrow Transplant; 2007 Aug; 13(8):965-74. PubMed ID: 17640601
[TBL] [Abstract][Full Text] [Related]
56. Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
Lanino E; Rondelli R; Locatelli F; Messina C; Pession A; Balduzzi A; Favre C; Santarone S; Rabusin M; Pollichieni S; Cesaro S; Dini G;
Biol Blood Marrow Transplant; 2009 Jun; 15(6):741-8. PubMed ID: 19450759
[TBL] [Abstract][Full Text] [Related]
57. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
58. Rehabilitation of chronic graft versus host disease in children. A clinical series.
Carenzio G; Gherardi P; Bardoni MT; Zecca M; Bonetti F; Locatelli F; Dalla Toffola E
Eura Medicophys; 2007 Dec; 43(4):445-50. PubMed ID: 18084166
[TBL] [Abstract][Full Text] [Related]
59. Chronic graft-versus-host disease.
Cutler C; Antin JH
Curr Opin Oncol; 2006 Mar; 18(2):126-31. PubMed ID: 16462180
[TBL] [Abstract][Full Text] [Related]
60. TLR9 expression is related to immune activation but is impaired in individuals with chronic immune activation.
Ayash-Rashkovsky M; Bentwich Z; Borkow G
Int J Biochem Cell Biol; 2005 Nov; 37(11):2380-94. PubMed ID: 16024265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]